Table 3 Comparisons of pathological characteristics between diabetic group and non-diabetic group
Characteristic | Diabetic group (n = 72) [%] | Non-diabetic group (n = 144) [%] | χ2 | P value |
|---|---|---|---|---|
T stage | ||||
T1 | 16 (22.2) | 36 (25.0) | 0.809 | 0.667 |
T2 | 35 (48.6) | 74 (51.4) | ||
T3 | 21 (29.2) | 34 (23.6) | ||
Axillary lymph nodes | ||||
Positive | 45 (62.5) | 75 (52.1) | 2.109 | 0.146 |
Negative | 27 (37.5) | 69 (47.9) | ||
Pathological types | ||||
Invasive ductal carcinoma | 66 (91.7) | 136 (94.4) | 0.890 | 0.828 |
Invasive lobular carcinoma | 3 (4.2) | 3 (2.1) | ||
Invasive papilloma | 2 (2.8) | 3 (2.1) | ||
Mucinous adenocarcinoma | 1 (1.4) | 2 (1.4) | ||
Tumor stage | ||||
I | 4 (5.6) | 19 (13.2) | 2.966 | 0.227 |
II | 27 (37.5) | 51 (35.4) | ||
III | 41 (56.9) | 74 (51.4) | ||
Histological grade | ||||
WHO I | 5 (6.9) | 9 (6.2) | 2.099 | 0.350 |
WHO II | 42 (58.3) | 98 (68.1) | ||
WHO III | 25 (34.7) | 37 (25.7) | ||
Lymph node metastasis | ||||
Positive | 45 (62.5) | 55 (38.2) | 11.410 | <0.001 |
Negative | 27 (37.5) | 89 (61.8) | ||
ER | ||||
Positive | 42 (58.3) | 88 (61.1) | 0.155 | 0.694 |
Negative | 30 (41.7) | 56 (38.9) | ||
PR | ||||
Positive | 40 (55.6) | 91 (63.2) | 1.174 | 0.279 |
Negative | 32 (44.4) | 53 (36.8) | ||
Her-2 | ||||
Positive | 25 (34.7) | 66 (458) | 2.431 | 0.119 |
Negative | 47 (65.3) | 78 (54.2) | ||
P-gp | ||||
Positive | 60 (83.3) | 121 (84.0) | 0.017 | 0.896 |
Negative | 12 (16.7) | 23 (16.0) | ||
Topo-II | ||||
Positive | 64 (88.9) | 132 (91.7) | 0.441 | 0.507 |
Negative | 8 (11.1) | 12 (8.3) | ||
Gst-π | ||||
Positive | 39 (54.2) | 70 (48.6) | 0.593 | 0.441 |
Negative | 33 (45.8) | 74 (51.4) | ||